These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4385992)

  • 21. [Bordetella pertussis as an immunological adjuvant].
    Finger H; Emmerling P
    Dtsch Med Wochenschr; 1970 Jan; 95(2):89-90. PubMed ID: 4311955
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations.
    Gracia A; Polewicz M; Halperin SA; Hancock RE; Potter AA; Babiuk LA; Gerdts V
    Vaccine; 2011 Feb; 29(8):1595-604. PubMed ID: 21215343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential migration of helper and precursor spleen cells following immunization.
    Cantor H
    Eur J Immunol; 1971 Dec; 1(6):462-4. PubMed ID: 4112275
    [No Abstract]   [Full Text] [Related]  

  • 24. [Increase of recirculating immunocompetent lymphocytes induced by Bordetella pertussis (proceedings)].
    Hof H; Finger H; Wirsing C
    Zentralbl Bakteriol Orig A; 1976 Aug; 235(1-3):71-7. PubMed ID: 185849
    [No Abstract]   [Full Text] [Related]  

  • 25. Biological activity of Bordetella pertussis in lipopolysaccharide-resistant mice.
    Wirsing von Koenig CH; Heymer B; Hof H; Finger H; Emmerling P
    Infect Immun; 1981 Jul; 33(1):223-30. PubMed ID: 6266965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological and histological reactions to respiratory administration of ribosomal Bordetella pertussis vaccine in mice.
    Bartlema HC; Braunius R
    Z Erkr Atmungsorgane; 1979 May; 153(2):254-60. PubMed ID: 232799
    [No Abstract]   [Full Text] [Related]  

  • 27. Taxonomic distribution of the antigen eliciting bactericidal antibody for Bordetella pertussis.
    Dolby JM; Ackers JP
    J Gen Microbiol; 1975 Apr; 87(2):239-44. PubMed ID: 49392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Murine model for pertussis vaccine encephalopathy: role of the major histocompatibility complex; antibody to albumin and to Bordetella pertussis and pertussis toxin.
    Steinman L; Weiss A; Adelman N; Lim M; Oehlert J; Zuniga R; Hewlett E; Falkow S
    Dev Biol Stand; 1985; 61():439-46. PubMed ID: 2872126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extraction and partial purification of the histamine-sensitizing factor of Bordetella pertussis.
    Lehrer SB; Tan EM; Vaughan JH
    J Immunol; 1974 Jul; 113(1):18-26. PubMed ID: 4134061
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on the immunological adjuvant activity of Bordetella bronchiseptica in mice.
    Magyar T; Géresi M; Semjén G; Solténszky J; Réthy LA; Réthy L
    Acta Vet Hung; 1983; 31(1-3):31-5. PubMed ID: 6331140
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibody response to a protein antigen (ovalbumin) in dissociated spleen cell cultures from primed mice. Evidence for a suppressive effect of antigen.
    Salaman MR; Britton S
    Immunology; 1973 Jan; 24(1):55-65. PubMed ID: 4346599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular site of action of various adjuvants in antibody responses to hapten-carrier conjugates.
    Hamaoka T; Katz DH
    J Immunol; 1973 Nov; 111(5):1554-63. PubMed ID: 4126779
    [No Abstract]   [Full Text] [Related]  

  • 33. The antigen of Bordetella pertussis that induces bactericidal antibody and its relationship to protection of mice.
    Ackers JP; Dolby JM
    J Gen Microbiol; 1972 Apr; 70(2):371-82. PubMed ID: 4338965
    [No Abstract]   [Full Text] [Related]  

  • 34. Do we need a new vaccine to control the re-emergence of pertussis?
    Mills KH; Ross PJ; Allen AC; Wilk MM
    Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvants in the induction and enhancement of rat IgE responses.
    Jarrett EE; Hall E; Karlsson T; Bennich H
    Clin Exp Immunol; 1980 Jan; 39(1):183-9. PubMed ID: 6248278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunologic and biochemical properties of the histamine-sensitizing factor from Bordetella pertussis.
    Lehrer SB; Vaughan JH; Tan EM
    J Immunol; 1975 Jan; 114(1 Pt 1):34-9. PubMed ID: 46244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.
    Knight JB; Huang YY; Halperin SA; Anderson R; Morris A; Macmillan A; Jones T; Burt DS; Van Nest G; Lee SF
    Clin Exp Immunol; 2006 Jun; 144(3):543-51. PubMed ID: 16734625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of immunization schedule to standardize antibody response in mice to pertussis vaccines.
    Tiru M; Jäätmaa E; Gillenius P; Askelöf P
    Dev Biol Stand; 1985; 61():469-75. PubMed ID: 2872128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant and immunogenic activities of the 73kDa N-terminal alpha-domain of BrkA autotransporter and Cpn60/60kDa chaperonin of Bordetella pertussis.
    Cainelli Gebara VC; Risoléo L; Lopes AP; Ferreira VR; Quintilio W; Lépine F; Silva WD; Raw I
    Vaccine; 2007 Jan; 25(4):621-9. PubMed ID: 17011680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local and systemic opsonic adherent, hemagglutinating and rosette forming activity in mice induced by respiratory immunization with sheep red blood cells.
    Birnabaum S; Pinto M
    Z Immunitatsforsch Exp Klin Immunol; 1976 Mar; 151(1-2):69-77. PubMed ID: 183401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.